quipazine has been researched along with 1-methyl-d-lysergic acid butanolamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzini, M; Cagnotto, A; Cappelli, A; Emerit, BM; Giorgi, G; Hamon, M; Langer, T; Merahi, N; Skorupska, M; Vomero, S | 1 |
| Butini, S; Caccia, S; Cagnotto, A; Campiani, G; Cervo, L; Dalla Valle, F; Fracasso, C; Gemma, S; Goegan, M; Greco, G; Hamon, M; Mennini, T; Morelli, E; Nacci, V; Novellino, E | 1 |
2 other study(ies) available for quipazine and 1-methyl-d-lysergic acid butanolamide
| Article | Year |
|---|---|
Novel, potent, and selective 5-HT3 receptor antagonists based on the arylpiperazine skeleton: synthesis, structure, biological activity, and comparative molecular field analysis studies.
Topics: Animals; Crystallography, X-Ray; Guinea Pigs; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Pyrroloquinoxaline derivatives as high-affinity and selective 5-HT(3) receptor agonists: synthesis, further structure-activity relationships, and biological studies.
Topics: Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Blood-Brain Barrier; Brain; Guanidine; Guinea Pigs; Hybrid Cells; In Vitro Techniques; Ligands; Male; Pyrroles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Serotonin Antagonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 1999 |